Metastasis-suppressed C8161 melanoma cells arrest in lung but fail to proliferate

被引:68
作者
Goldberg, SF
Harms, JF
Quon, K
Welch, DR
机构
[1] Penn State Univ, Coll Med, Jake Gittlen Canc Res Inst, Hershey, PA 17033 USA
[2] Netherlands Canc Inst, Dept Mol Genet, Amsterdam, Netherlands
关键词
chromosome; 6; green fluorescent protein; metastasis; metastasis-suppressor gene;
D O I
10.1023/A:1006718800891
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The incidence of melanoma continues to increase at a rapid rate. As for most cancers, it is melanoma metastases, rather than the primary malignancy, that is the principal cause of death. We previously showed that the introduction of a normal copy of chromosome 6 into the metastatic human melanoma cell line C8161 suppresses metastasis at a step subsequent to tumor cells entering the bloodstream. To better define the step(s) in metastasis blocked by the addition of chromosome 6 we engineered cells that constitutively express green fluorescent protein (GFP). When these tagged, chromosome 6 hybrid cells were injected intravenously into athymic mice, grossly detectable metastases did not form. However, fluorescence microscopy revealed micro-metastases (single cells or clusters of < 10 cells) in the lungs, suggesting that these cells lodged in the lungs but failed to proliferate. Cells isolated from lung up to 60 days post-injection grew in culture and/or formed tumors when injected into the skin, indicating that they were still viable, but dormant. This result implies that the gene(s) on chromosome 6 interfere specifically with growth regulatory response in the lung, but not in the skin. Thus, the gene(s) responsible for metastasis suppression represents a new class of metastasis inhibitors acting at the final stages of the metastatic cascade - that is, affecting the ability of the cells to survive and proliferate at a specific secondary site.
引用
收藏
页码:601 / 607
页数:7
相关论文
共 29 条
[1]  
[Anonymous], J NATL CANCER I
[2]   Prognostic significance of micrometastatic bone marrow involvement [J].
Braun, S ;
Pantel, K .
BREAST CANCER RESEARCH AND TREATMENT, 1998, 52 (1-3) :201-216
[3]  
Chekmareva MA, 1998, CANCER RES, V58, P4963
[4]  
Dowlatshahi K, 1997, CANCER, V80, P1188, DOI 10.1002/(SICI)1097-0142(19971001)80:7<1188::AID-CNCR2>3.0.CO
[5]  
2-H
[6]  
FIDLER IJ, 1973, EUR J CANCER, V9, P223, DOI 10.1016/S0014-2964(73)80022-2
[7]   GENETIC-CONTROL OF CANCER METASTASIS [J].
FIDLER, IJ ;
RADINSKY, R .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (03) :166-168
[8]  
FOUNTAIN JW, 1990, CANCER SURV, V9, P645
[9]   Integrins and anoikis [J].
Frisch, SM ;
Ruoslahti, E .
CURRENT OPINION IN CELL BIOLOGY, 1997, 9 (05) :701-706
[10]  
FUJIMAKI T, 1993, INT J ONCOL, V2, P895